Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endoplasmic reticulum (ER) stress machinery, primarily known as the unfolded protein response (UPR), is a complex signal transduction network that monitors and maintains the protein-folding capacity of the ER. It is governed by three main transmembrane sensors: Inositol-requiring enzyme 1 (IRE1), Protein kinase RNA-like endoplasmic reticulum kinase (PERK), and Activating transcription factor 6 (ATF6). Under normal conditions, these sensors are kept inactive by the chaperone BiP; however, the accumulation of misfolded proteins causes BiP to dissociate, triggering the UPR to expand ER capacity and reduce protein load. If the stress is chronic or overwhelming, the machinery transitions from an adaptive, pro-survival phase to a terminal, pro-apoptotic phase, often involving the upregulation of CHOP. In diseases like cancer, the UPR is frequently hijacked to support tumor survival under hypoxic and nutrient-deprived conditions, whereas in neurodegenerative diseases, chronic ER stress contributes to neuronal loss. Therapeutic interventions target specific components of this machinery, such as PERK or IRE1 inhibitors to sensitize tumors, or chemical chaperones like 4-phenylbutyric acid to alleviate stress in metabolic disorders (Source: NIH, PubMed, UniProt).
Modulation of the three primary signaling arms (PERK, IRE1, and ATF6) to either restore endoplasmic reticulum proteostasis or induce programmed cell death in stressed cells.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Unfolded protein response (UPR) machinery (UPR).